PE20220903A1 - Compuestos y metodos de uso de los mismos como agentes antibacterianos - Google Patents

Compuestos y metodos de uso de los mismos como agentes antibacterianos

Info

Publication number
PE20220903A1
PE20220903A1 PE2021002266A PE2021002266A PE20220903A1 PE 20220903 A1 PE20220903 A1 PE 20220903A1 PE 2021002266 A PE2021002266 A PE 2021002266A PE 2021002266 A PE2021002266 A PE 2021002266A PE 20220903 A1 PE20220903 A1 PE 20220903A1
Authority
PE
Peru
Prior art keywords
compounds
methods
antibacterial agents
mycobacterial
inhibiting
Prior art date
Application number
PE2021002266A
Other languages
English (en)
Inventor
Brendan M Crowley
Philippe Nantermet
David Olsen
Takao Suzuki
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of PE20220903A1 publication Critical patent/PE20220903A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a compuestos de Formula; ( ) La invencion tambien proporciona metodos para inhibir el crecimiento de celulas micobacterianas asi como a un metodo para tratar infecciones por micobacterias por Mycobacterium tuberculosis.
PE2021002266A 2019-07-03 2020-06-02 Compuestos y metodos de uso de los mismos como agentes antibacterianos PE20220903A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2019/094601 WO2021000297A1 (en) 2019-07-03 2019-07-03 Compounds and methods of use thereof as antibacterial agents
PCT/CN2020/093887 WO2021000684A1 (en) 2019-07-03 2020-06-02 Compounds and methods of use thereof as antibacterial agents

Publications (1)

Publication Number Publication Date
PE20220903A1 true PE20220903A1 (es) 2022-05-30

Family

ID=74100984

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2021002266A PE20220903A1 (es) 2019-07-03 2020-06-02 Compuestos y metodos de uso de los mismos como agentes antibacterianos

Country Status (20)

Country Link
US (1) US20220235041A1 (es)
EP (1) EP3997073A4 (es)
JP (1) JP7183455B2 (es)
KR (1) KR20220028015A (es)
CN (1) CN114341119A (es)
AU (1) AU2020300400B2 (es)
BR (1) BR112021026762B1 (es)
CA (1) CA3145555C (es)
CL (1) CL2021003592A1 (es)
CO (1) CO2021018154A2 (es)
CR (1) CR20220003A (es)
EA (1) EA202290215A1 (es)
EC (1) ECSP21093897A (es)
GE (1) GEP20247616B (es)
IL (1) IL289336A (es)
JO (1) JOP20210353A1 (es)
MX (1) MX2021015841A (es)
PE (1) PE20220903A1 (es)
WO (2) WO2021000297A1 (es)
ZA (1) ZA202110692B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4296674A1 (en) 2022-06-20 2023-12-27 Université Toulouse III - Paul Sabatier Innovative molecules decreasing virulence of mycobacterium for the treatment of tuberculosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0920421B1 (en) * 1996-08-21 2002-11-06 PHARMACIA & UPJOHN COMPANY Isoxazoline derivatives useful as antimicrobials
ATE222894T1 (de) * 1998-02-13 2002-09-15 Upjohn Co Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
EP1443930A1 (en) * 2001-10-25 2004-08-11 AstraZeneca AB Isoxazoline derivatives useful as antimicrobials
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
CN101220000B (zh) * 2007-12-28 2010-12-22 天津药物研究院 酰氯和磺酰氯类衍生物及其用途
WO2017066964A1 (en) * 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents

Also Published As

Publication number Publication date
AU2020300400A1 (en) 2022-01-27
BR112021026762B1 (pt) 2024-01-02
EP3997073A1 (en) 2022-05-18
CA3145555A1 (en) 2021-01-07
IL289336A (en) 2022-02-01
WO2021000684A1 (en) 2021-01-07
EP3997073A4 (en) 2023-07-26
CA3145555C (en) 2023-10-03
US20220235041A1 (en) 2022-07-28
AU2020300400B2 (en) 2023-04-13
KR20220028015A (ko) 2022-03-08
JP2022530709A (ja) 2022-06-30
CR20220003A (es) 2022-02-08
ECSP21093897A (es) 2022-01-31
GEP20247616B (en) 2024-03-25
ZA202110692B (en) 2023-10-25
BR112021026762A8 (pt) 2023-01-31
EA202290215A1 (ru) 2022-03-25
CO2021018154A2 (es) 2022-01-17
MX2021015841A (es) 2022-02-03
CN114341119A (zh) 2022-04-12
CL2021003592A1 (es) 2022-10-07
JOP20210353A1 (ar) 2023-01-30
JP7183455B2 (ja) 2022-12-05
BR112021026762A2 (pt) 2022-02-15
WO2021000297A1 (en) 2021-01-07

Similar Documents

Publication Publication Date Title
CL2020003007A1 (es) Lactamas biciclicas y metodos de uso de las mismas (divisional solicitud no. 3486-2017)
CL2021000361A1 (es) Nuevos compuestos heterocíclicos como inhibidores de monoacilglicerol lipasa
CO2019009373A2 (es) Compuestos heterocíclicos útiles como inhibidores duales de atx/ca.
CO2021002382A2 (es) Nuevos compuestos heterocíclicos como inhibidores de la monoacilglicerol lipasa
UY36201A (es) Herbicidas de piperidinona
UY35953A (es) ?derivados de pirimidiniloxi benceno como herbicidas?.
PE20180040A1 (es) Derivados de 2-(feniloxi o feniltio)pirimidina como herbicidas
UY32606A (es) Sulfonamidas nematocidas
CL2017000103A1 (es) Derivados de bis(aril)catecol como herbicidas
DOP2019000140A (es) Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih
CL2022000093A1 (es) Imidazopirimidinas como inhibidores de eed y uso de estas
CR20170496A (es) Nuevos compuestos y derivados de sulfonimidoilpurinona para el tratamiento y profilaxis de infecciones víricas
CL2018002583A1 (es) Derivado de morfolina
MX2020003921A (es) Proceso para producir compuestos de tipo piridazinona herbicidas.
CL2023000594A1 (es) Compuestos heterocíclicos
EA201590828A1 (ru) Насыщенные азотсодержащие и n-ацилированные гетероциклы, усиливающие действие активного антибиотика против микобактерий
CO2022000186A2 (es) Nuevos compuestos heterocíclicos
CL2021000421A1 (es) Nuevo derivado de amina heterocíclico y composición farmacéutica que lo comprende.
UY39385A (es) Nuevos compuestos heterocíclicos para combatir los hongos fitopatógenos
PE20220903A1 (es) Compuestos y metodos de uso de los mismos como agentes antibacterianos
CO2019000506A1 (es) Cetoximas sustituidas con piridazinonas como herbicidas
UY39086A (es) Compuestos heterocíclicos fusionados y su uso como agentes para el control de plagas
CU24562B1 (es) Inhibidores de beta-lactamasa útiles contra infecciones bacterianas
UY38749A (es) Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
UY38024A (es) Compuestos de fluoralquenilo, proceso de preparación y uso de los mismos